Long-term outcome of oesophageal atresia in adolescence (TransEAsome): a national French cohort study protocol.
Mélanie Leroy, Madeleine Aumar, Marie Duhamel...
https://pubmed.ncbi.nlm.nih.gov/39800411/Actively Recruiting
Led by University Hospital, Lille · Updated on 2026-04-22
300
Participants Needed
33
Research Sites
N/A
Total Duration
Researchers are studying adolescents aged 13 to 14 who were born with esophageal atresia, a birth defect where the esophagus is interrupted and ends in a dead end. Surgery is required soon after birth to restore esophagus continuity, but many children continue to experience health issues such as acid reflux, eating difficulties, breathing problems, and growth challenges throughout life. This study aims to assess the long-term outcomes and develop detailed molecular profiles of esophageal tissue and blood samples from this rare condition. The study includes two groups adolescents with esophageal atresia and a control group without the condition. Participants undergo upper gastrointestinal endoscopy with biopsy sampling as part of their usual care. Quality of life questionnaires designed specifically for this research, including the Pediatric Quality of Life Inventory and EA-QoL, are used. Clinical and molecular data from tissue and blood samples will be analyzed together to understand disease impact and molecular changes. Data will be stored and shared through the France Cohortes platform. Participants will have their gastroesophageal reflux disease GERD status assessed along with measures of quality of life, nutrition, and respiratory health. Researchers will analyze molecular profiles from plasma and esophageal biopsies, and look at factors associated with GERD from birth through adolescence. Participation involves clinical data collection, questionnaires, and biological sampling during routine care. Data from this study will contribute to understanding the long-term effects of esophageal atresia and aid future research.
CONDITIONS
Long Term Outcome of Easophageal Atresia : Transmics Profiles in Adolescence
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University Hospital, Lille
Lead Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single timepoint at ages 13 to 14 years
Participants undergo upper GI endoscopy with esophageal mucosal biopsy and complete quality of life questionnaires to assess digestive health and multi-omic profiles.
1 visit (in-person)
Duration - Up to 1 year following diagnostic evaluation
Participants are observed for long-term outcomes including gastroesophageal reflux disease prevalence, nutritional status, respiratory complications, and multi-omics profiles.
Follow-up assessments may occur depending on participant group
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Mélanie Leroy, Madeleine Aumar, Marie Duhamel...
https://pubmed.ncbi.nlm.nih.gov/39800411/University Hospital, Lille
Lead Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Collaborating Sponsor